Bioceres Crop Solutions faces significant headwinds as its core Argentine agricultural markets drive a 25.5% year-over-year revenue contraction observed in 2026Q2.
Price trend, volume and key moving averages
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 14, 2026 | -$0.39-542.0% vs -$0.06 | $56M-29.2% vs $79M |
Q2 2026 May 11, 2026 | -$0.16-220.0% vs -$0.05 | $39M-27.7% vs $55M |
Q2 2026 Mar 13, 2026 | -$0.08-214.3% vs $0.07 | $74M-23.3% vs $96M |
Q4 2025 Nov 13, 2025 | -$0.12-200.0% vs -$0.04 | $78M-18.1% vs $95M |
Chemours (NYSE: CC - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) are both materials companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk. Risk and Volatility Chemours has a beta of
Rayonier Advanced Materials (NYSE: RYAM - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) are both small-cap materials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk. Insider and Institutional Ownership 68.6%
Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) and Neo Performance Materials (OTCMKTS:NOPMF - Get Free Report) are both small-cap materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Profitability This table compares Bioceres
Bioceres Crop Solutions Corp. (BIOX) Q4 2026 Earnings Call Transcript
Benchmark BIOX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Bioceres Crop Solutions Corp. (BIOX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.23 | $14.8M | -0.06 | -28.66% | -93.45% | -170.03% | — | |
| $4.47 | $1.59B | 77.20 | 146.73% | 15.55% | 57.93% | — | |
| $5.63 | $705.03M | -0.18 | -18.34% | -148.38% | -302.92% | 41.33% | |
| $11.90 | $53.27B | 52.80 | 2.92% | 5.66% | 4.04% | 0.88% | |
| $0.96 | $27.54M | -0.51 | -5.88% | -10.7% | -27.84% | — | |
| $103.63 | $12.29B | 26.18 | 37.55% | 26.93% | 544.26% | — |
Bioceres Crop Solutions Corp. (BIOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BIOX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Bioceres Crop Solutions Corp. (BIOX) stock FAQ — growth, dividends, profitability & financials explained
Bioceres Crop Solutions Corp. (BIOX) reported $246.3M in revenue over the trailing twelve months. Revenue was $237.8M in fiscal year 2026. That is 154% more than the $93.7M of fiscal year 2017.
Bioceres Crop Solutions Corp. (BIOX) revenue fell by 24.3% over the trailing twelve months, compared with the twelve months before.
No. Bioceres Crop Solutions Corp. (BIOX) reported a net loss of $230.2M over the trailing twelve months.
Bioceres Crop Solutions Corp. (BIOX) had a return on equity (ROE) of -170.0% over the trailing twelve months. A negative ROE means the company lost money over the period.
Bioceres Crop Solutions Corp. (BIOX) generated $51.6M in free cash flow in fiscal year 2026.
